GRAS Notices
-
GRN No. 1003
Bifidobacterium longum subsp. infantis M-63
Intended Use: | Intended for use as an ingredient in non-exempt cow milk- and soy-based infant formula for term infants at a level up to 1 x 108 colony forming units (CFU)/g of powdered formula, and in certain conventional foods in the following categories at a level up to 1.25 x 1010 CFU per serving: breads and baked goods; ready-to-eat and hot breakfast cereals; fruit juices, nectars, and blends; dairy products and dairy substitutes; candy; condiment sauces; gelatin desserts; peanut and other nut butters and spreads; snack foods; and infant and toddler foods. |
---|---|
Basis: | Scientific procedures |
Notifier: | Morinaga Milk Industry Co., Ltd |
Notifier Address: |
33-1, Shiba 5-Chome, Minato-ku Tokyo 108-8384 JAPAN |
GRAS Notice (releasable information): | GRN 1003 with amendments (in PDF) (2.3 MB) |
Date of closure: | Apr 26, 2022 |
FDA's Letter: | FDA has no questions (in PDF) (75 kB) |
-